NanoVibronix Inc
0.0001 (0.03%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 70,334
Bid Price 0.3001
Ask Price 0.32
News -
Day High 0.3168


52 Week Range


Day Low 0.3001
Company Name Stock Ticker Symbol Market Type
NanoVibronix Inc NAOV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0001 0.03% 0.305 19:56:46
Open Price Low Price High Price Close Price Prev Close
0.3024 0.3001 0.3168 0.3086 0.3049
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
280 70,334 $ 0.3049973 $ 21,452 - 0.22 - 1.36
Last Trade Time Type Quantity Stock Price Currency
19:56:10 formt 1,000 $ 0.305 USD


Draw Mode:

NanoVibronix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.00M 32.79M 32.63M $ 1.70M $ - -0.57 -1.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 0.20%

more financials information »

NanoVibronix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NAOV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.30850.3240.2871010.3075726109,171-0.0035-1.13%
1 Month0.26460.37820.2220.2907432282,7390.040415.27%
3 Months0.40010.6450.220.49627171,422,037-0.0951-23.77%
6 Months0.640.730.220.5040269844,567-0.335-52.34%
1 Year0.801.360.220.7610855832,396-0.495-61.88%
3 Years2.754.750.221.953,445,062-2.45-88.91%
5 Years4.58485.000.221.962,156,282-4.28-93.35%

NanoVibronix Description

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.